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Background: The musculoskeletal disorders in working population represent one of the most worrying work-
related health issues at the present time and although the very great majority of available data on the subject focus
on musculoskeletal disorders defined by anatomical site, a growing number of studies indicate the low prevalence
of disorders strictly confined to a specific anatomical site. The objective of this study was to describe the prevalence
and characteristics of multisite musculoskeletal symptoms (multisite MS) in a large French working population.
Methods: This study was performed on surveillance data of the cross-sectional survey (2002–2005) conducted by a
network of occupational physicians in the working population of the Loire Valley region (from 20 to 59 years old).
Data concerning MS were collected in the waiting room of the occupational physicians by means of the self-
administrated standardized NORDIC questionnaire.
Results: The study population comprised 3,710 workers (2,162 men (58%) and 1,548 women (42%)) with a mean
age of 38.4 years (standard deviation: 10.4 years). The prevalence of MS during the past 12 months was 83.8% with
95% confidence interval of [82.8-85.3] for men and 83.9% [82.0-85.7] for women. The prevalence of subacute MS
(lasting at least 30 days) over the past 12 months was 32.8% [30.9-34.8] for men and 37.3% [34.9-39.7] for women.
Two-thirds of workers reported MS in more than one anatomical site and about 20% reported MS lasting at least
30 days in more than one anatomical site. The anatomical sites most frequently associated with other MS were the
upper back, hip, elbow and neck. The majority of these multisite MS were widespread, involving at least two of the
three anatomical regions (upper limb, axial region and lower limb).
Conclusions: The frequency and extent of multisite MS reported by workers are considerable. Further research
must be conducted in this field in order to provide a better understanding of the characteristics and determinants
of these multisite MS.Background
All over the world, musculoskeletal disorders (MSDs)
are responsible for considerable human, social and
work-related burdens in terms of pain, distress at work,
disability and quality of life. This major health issue has
been recognized by the United Nations and the World
Health Organization, which approved The Bone and
Joint Decade 2000–2010 [1]. MSDs in working popula-
tion are the leading cause of morbidity and work* Correspondence: elparot@chu-angers.fr
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distribution, and reproduction in any mediumdisability in the European Union [2,3] and represent one
of the most worrying work-related health issues at the
present time. According to Eurostat [4], the Statistical
Office of the European Communities, MSDs are the
most widespread and most costly work-related health
problem in Europe, affecting about 45 million workers.
A better understanding of the mechanisms responsible
for the onset and progression of these disorders consti-
tutes a major public health challenge in order to im-
prove the prevention, management and prognosis of
these disorders. For many years, research has therefore
been largely devoted to risk factors and prognostic fac-
tors of MSDs demonstrating, regardless of the siteCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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mechanical, psychosocial and organizational stresses.
The very great majority of the available data (descrip-
tive, aetiological and prognostic) focus on MSDs defined
by anatomical site. Recent studies support a more global
approach to musculoskeletal disorders analysing the ex-
tent of musculoskeletal symptoms (MS) and especially
the number of symptomatic anatomical sites rather than
a particular site, either in the general population [5-17]
or in the working population [18-24]. The results of
these studies indicate the moderate prevalence of symp-
toms strictly confined to a specific anatomical site (esti-
mated prevalence of 15 to 30% depending on the study)
and the predominance of multisite MS (prevalence in
the general population about 1/3 and 2/3 in the working
population).
This characterization of MS based on the number of
symptomatic sites regardless of the anatomical sites
appears to be particularly suitable to study widespread
pain according the American College of Rheumatology
definition (WSP) [25,26]. However, this appears to be in-
sufficient to describe less widespread multisite MS, as
Picavet et al. clearly described that although involvement
of several sites in the same region was very common, in-
volvement of several sites located in distinct regions was
also common [15]. It would be reasonable to suppose
that when four anatomical sites are affected, the patho-
physiology and prognosis may vary according to their re-
gional distribution (symptoms affecting a single
anatomical region or extending to more than one re-
gion). Croft challenged the conventional approach to
MS defined by anatomical site by proposing a new and
more relevant definition taking into account the extent
of MS by region [27].
Although several teams have started to describe the
profiles of these multisite MS [15,16,20,24] or 2-by-2
combinations corresponding to these multisite MS
[18,19,21,24,28-31], very few studies on multisite MS
and their corresponding profiles have been published.
Many of these studies were also conducted on very spe-
cific populations [18,20,23,24,32,33] and/or small sample
sizes [18,20,23,24,32].
The objective of this study, based on surveillance data
in a large regional workforce, was to describe the preva-
lence and characteristics of multisite MS in a large
population of workers.
Methods
Study design and population
The study was based on surveillance data collected by a
network of occupational physicians (OPs) in the working
population of the Loire Valley region (Central West
France) [34]. The Pays de la Loire study was approved
by both appropriate national committees : the Comitéconsultatif sur le traitement de l’information en matière
de recherché dans le domaine de la santé (CCTIRS n°01-
215) and the Commission nationale de l’informatique et
des libertés (CNIL n°901 273).
The economic structure of this region (5% of the
French working population) is diversified and similar to
that of most French regions [35].
All French workers, including temporary and part-
time workers, undergo a mandatory annual health exam-
ination by an OP in charge of the medical surveillance
of a group of companies. Eighty-three OPs out of 460
(18% participation), representative of the region’s OPs,
participated in the study. Each OP was trained by the
investigators to randomly include workers undergoing a
mandatory regularly-scheduled health examination be-
tween April 2002 and April 2005. The inclusion process
followed a two-stage sampling procedure: first, the re-
search team chose 15–45 half-days of scheduled exami-
nations for each OP. Next, using random sampling
tables, each OP selected 1 out of 10 workers from the
schedule on the half-days of worker examinations con-
sidered. Among the regularly-scheduled health examin-
ation which had thus been selected (approximately 2.2%
of the workers under surveillance by the 83 OPs), fewer
than 10% of the selected workers were excluded (no
shows, refusals, already included).
Data
Data analysed in this article were collected by a ques-
tionnaire filled in by the workers during their annual
visit. In particular, this questionnaire collected informa-
tion on sociodemographic characteristics and on the
presence and sites of MS. The presence and sites of MS
were documented by a French version of the NORDIC
questionnaire [36] including a mannequin with the ana-
tomical sites considered, the standardized scale routinely
used by occupational physicians for the detection of MS
[37].
The following anatomical sites were studied: neck,
shoulder/arm, elbow/forearm, hand/wrist, upper back,
lower back, hip/thigh, knee/lower leg and ankle/foot.
Two definitions of MS were used in this article:
 presence of symptoms during the past 12 months by
site;
 presence of symptoms lasting at least 30 days
(prolonged) during the past 12 months by site.
For bilateral anatomical sites, MS were classed as
present if they were reported on either or both sides of
the body.
In results presented by anatomical region (axial, upper
limb and lower limb), the neck was considered to be
part of the upper limb. The presence of MS in an
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presence in at least one site within the region for at least
30 days.
Multisite MS are defined by the presence of symptoms
affecting more than one anatomical site on 9 studied
sites.
Statistical analysis
Classical statistical analyses were performed using SPSS
software (v15; SPSS Inc., Chicago, IL, USA). All analyses
were performed separately in men and women. The stat-
istical unit was the individual, prevalence rates were cal-
culated by dividing the number of subjects reporting
symptoms (unilateral or bilateral) for the site of interest
over the total number of responding subjects together
with the 95% confidence intervals. Categorical data were
compared with the Chi-square test or Fisher's exact test
and a Mantel-Haenszel extension of the chi-square test
for trend was used to test a linear trend. The limit of sig-
nificance was 0.05.
Results
The study population comprised 3,710 workers (2,162
men (58%), 1,548 women (42%), mean age: 38.4, SD:
10.4 years) out of 184,600 (2.0% sample) workers exam-
ined by the 83 OPs. Subjects mainly worked in service
industries (59%), meat and manufacturing industries
(34%), and more rarely in the construction (6%) and
agriculture (1.5%) sectors. Men were mainly skilled and
unskilled blue collar workers (56%), in intermediate
occupations and technicians (25%), and managers and
professionals (10%). Most women were low-grade white
collar workers (52%), skilled and unskilled blue collar
workers (24%), and in intermediate occupations and
technicians (19%). Most workers, regardless of gender,
presented a long service in the current job: more than
ten years in 56% of cases, more than two years in 84% of
cases and more than one year in 94% of cases.
Prevalence of musculoskeletal symptoms (MS)
A total of 3,109 workers reported at least one MS affect-
ing the limbs and/or spine during the past 12 months
(1,811 men and 1,298 women). The corresponding
prevalence rates were 83.8% with 95% confidence inter-
val of [82.8-85.3] for men and 83.9% [82.0-85.7] for
women.
At least one MS lasting at least 30 days during the past
12 months was reported by 1,287 workers (710 men and
577 women) with a prevalence of 32.8% [30.9-34.8] for
men and 37.3% [34.9-39.7] for women (p = 0.005).
Prevalences of MS in the nine anatomical sites during
the past 12 months are summarized in Table 1. The
most frequent site was the lower back with MS reported
by 59.3% [57.2-61.3] of men and 54.0% [51.5-56.5] ofwomen (p = 0.0015) and with MS lasting at least 30 days
reported by 16.6% [15.4-17.8] of all workers.
The other most frequent sites of MS were the neck,
shoulder and wrist in men and women, the upper back
in women and the knee or lower leg in men with signifi-
cant differences (for MS over the past 12 months and
MS lasting at least 30 days over the past 12 months) be-
tween the two sexes (with the exception of the knee or
lower leg) (Table 1).
Prevalence of multisite MS
Two-thirds of workers reported the presence of MS in-
volving more than one anatomical site (Table 2): 63.2%
[61.1-65.2] of men and 68.3% [66.0-70.7] of women
(p = 0.001).
Slightly less than one third of workers reported MS in-
volving four or more anatomical sites (27.3% of men and
34.0% of women), and 10% reported MS involving six or
more sites (8.2% of men and 12.7% of women).
Slightly less than 20% of workers reported MS lasting
at least 30 days in more than one anatomical site
(Table 3): 17.1% [15.5-18.7] of men and 22.4% [20.3-24.4]
of women (p< 0.0001) and 6.3% of workers reported MS
lasting at least 30 days in four or more anatomical sites
(4.9% of men and 8.3% of women), while 4.5% of women
reported MS lasting at least 30 days in five or more ana-
tomical sites (versus 2.0% of men).
The prevalence of MS affecting two to four anatomical
sites was three to twelve times more common than
prevalence of MS affecting only one site in workers who
reported musculoskeletal symptoms at a given anatom-
ical site whatever it is (Figure 1).
More than 80% of MS lasting at least 30 days involving
the upper back, hip, neck and elbow were associated
with other MS (multisite MS). MS lasting at least 30 days
involving the knee or lower leg, lower back and ankles
were more frequently isolated (1/4 to 1/3 of cases).
The prevalence of multisite MS increased slightly but
significantly with increasing age (test for linear trend:
p = 0.001 for the men and p< 0.0001 for the women,
Table 2). For the prevalence of multisite MS lasting at
least 30 days, we see a significant increase with in-
creasing age: slight for the men (test for linear trend:
p< 0.0001, Table 3) but more marked for the women
(test for linear trend: p< 0.0001, Table 3).
For the women, the prevalence of multisite MS was
associated with the occupational category (p = 0.006,
Table 2), we see a prevalence more raised for skilled and
unskilled workers versus associate professionals and
technicians.
The prevalence of multisite MS lasting at least 30 days
was associated with the occupational category for the
men and women (Table 3) with, for the men, a slightly
lower prevalence for the managers and professionals
Table 1 Prevalence (%) and 95% confidence intervals (CI) of musculoskeletal symptoms during the past 12 months
among men and women
Symptoms: n (%) CI Men (N= 2,162) Women (N=1,548)
Musculoskeletal symptoms:
Neck symptoms** 725 (33.5) 31.5-35.5 747 (48.3) 45.8-50.7
Shoulder or upper arm symptoms* 735 (34.0) 32.0-36.0 601 (38.8) 36.4-41.3
Elbow or forearm symptoms 371 (17.2) 15.6-18.7 261 (16.9) 15.0-18.7
Wrist or hand symptoms** 468 (21.6) 19.9-23.4 463 (29.9) 27.6-32.2
Upper back symptoms** 451 (20.9) 19.1-22.6 503 (32.5) 30.2-34.8
Low back symptoms* 1281 (59.3) 57.2-61.3 836 (54.0) 51.5-56.5
Hip or thigh symptoms 360 (16.7) 15.1-18.2 278 (18.0) 16.0-19.9
Knee or lower leg symptoms 611 (28.3) 26.4-30.2 410 (26.5) 24.3-28.7
Ankle or foot symptoms 339 (15.7) 14.1-17.2 230 (14.9) 13.1-16.6
Musculoskeletal symptoms lasting at least 30 days:
Neck symptoms** 142 (6.6) 5.5-7.6 185 (12.0) 10.3-13.6
Shoulder or upper arm symptoms** 197 (9.1) 7.9-10.3 202 (13.0) 11.4-14.7
Elbow or forearm symptoms 128 (5.9) 4.9-6.9 112 (7.2) 5.9-8.5
Wrist or hand symptoms** 130 (6.0) 5.0-7.0 154 (9.9) 8.5-11.4
Upper back symptoms** 121 (5.6) 4.6-6.6 174 (11.2) 9.7-12.8
Low back symptoms 352 (16.3) 14.7-17.8 264 (17.1) 15.2-18.9
Hip or thigh symptoms 102 (4.7) 3.8-5.6 91 (5.9) 4.7-7.1
Knee or lower leg symptoms 189 (8.7) 7.6-9.9 146 (9.4) 8.0-10.9
Ankle or foot symptoms 109 (5.0) 4.1-6.0 89 (5.7) 4.6-6.9
Significant differences between men and women: * p< 0.01, ** p< 0.0001.
Table 2 Prevalence (%) and 95% confidence intervals (CI) of multisite musculoskeletal symptoms (MS) during the past
12 months among men and women
Multisite MS: n (%) CI Men (N= 2,162) Women (N=1,548)
By genre* 1366 (63.2) 61.1-65.2 1058 (68.3) 66.0-70.7
By age group (test for linear trend) }{
16-29 years 296 (57.6) 53.3-61.9 228 (63.2) 58.2-68.1
30-39 years 413 (63.5) 59.8-67.2 268 (62.5) 57.9-67.1
40-49 years 393 (64.2) 60.4-68.0 358 (73.5) 69.6-77.4
50-63 years 259 (68.3) 63.7-73.0 204 (75.6) 70.4-80.7
By occupational category†
Managers and professionals 134 (63.8) 57.3-70.3 52 (66.7) 56.2-77.1
Associate professionals/technicians 337 (62.4) 58.3-66.5 195 (67.5) 62.1-72.9
Employees 113 (60.1) 53.1-67.1 523 (65.5) 62.2-68.8
Skilled and unskilled workers 773 (63.9) 61.2-66.6 285 (75.6) 71.3-79.9
By economic activity
Service industries 664 (61.6) 58.7-64.5 726 (66.4) 63.6-69.2
Meat and manufacturing industries 559 (65.1) 61.9-68.3 293 (73.1) 68.7-77.4
Construction 123 (65.1) 58.3-71.9 16 (64.0) 45.2-82.8
Agriculture 19 (61.3) 44.1-78.4 19 (76.0) 59.3-92.7
Significant differences between men and women: * p< 0.01, ** p< 0.0001.
Significant differences among men: } p< 0.01, }} p< 0.0001.
Significant differences among women: † p< 0.01, { p< 0.0001.
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Table 3 Prevalence (%) and 95% confidence intervals (CI) of multisite musculoskeletal symptoms (MS) lasting at least
30 days during the past 12 months among men and women
Multisite MS: n (%) CI Men (N= 2,162) Women (N=1,548)
By genre** 370 (17.1) 15.5-18.7 346 (22.4) 20.3-24.4
By age group (test for linear trend) }}{
16-29 years 48 (9.3) 6.8-11.9 43 (11.9) 8.6-15.3
30-39 years 97 (14.9) 12.2-17.7 72 (16.8) 13.2-20.3
40-49 years 130 (21.2) 18.0-24.5 132 (27.1) 23.2-31.1
50-63 years 93 (24.5) 20.2-28.9 99 (36.7) 30.9-42.4
By occupational category}
Managers and professionals 22 (10.5) 6.3-14.6 19 (24.4) 14.8-33.9
Associate professionals/technicians 86 (15.9) 12.8-19.0 54 (18.7) 14.2-23.2
Employees 30 (16.0) 10.7-21.2 170 (21.3) 18.5-24.1
Skilled and unskilled workers 232 (19.2) 17.0-21.4 102 (27.1) 22.6-31.5
By economic activity†
Service industries 170 (15.8) 13.6-17.9 228 (20.9) 18.5-23.3
Meat and manufacturing industries 160 (18.6) 16.0-21.2 108 (27.0) 22.6-31.3
Construction 34 (18.0) 12.5-23.5 2 (8.0) 1.0-26.0#
Agriculture 5 (16.1) 3.2-29.1 6 (24.0) 7.3-40.7
Significant differences between men and women: * p< 0.01, ** p< 0.0001.
Significant differences among men: } p< 0.01, }} p< 0.0001.
Significant differences among women: † p< 0.01, { p< 0.0001.
# Estimation of CI with Fisher’s exact method (np or nq< 5).
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skilled and unskilled workers (p = 0.052). Furthermore,
for the women, we also observe a significant association
between prevalence of multisite MS lasting at least
30 days and the activity sector with a higher prevalence
for the meat and manufacturing industries versus the
service industries (p = 0.026, Table 3).
MS by anatomical region
The anatomical regions most frequently involved were
the axial and upper limb regions with a prevalence of
MS lasting at least 30 days over the past 12 months of
18 to 23% (Table 4).
About one quarter of subjects (Table 5) reported the
presence of MS involving a single anatomical region dur-
ing the past 12 months (25.7% of men and 21.9% of
women), usually involving axial regions in men (45.4% of
symptoms localized to one region) and the upper limb
in women (54.3% of symptoms localized to one region).
One-third of subjects (31.3% of men and 34.2% of
women) reported the presence of MS involving two ana-
tomical regions during the past 12 months (axial and
upper limb for 2/3 of them) and 27.2% reported disor-
ders involving the three anatomical regions studied:
axial, upper limb and lower limb.
Nine to 12% of subjects reported the presence of MS
in two anatomical regions for at least 30 days (Table 6)
with a predominance of symptoms affecting the axialand upper limb regions (51.3% of symptoms localized to
two regions).
More than 90% of multisite MS concerned two or three
anatomical regions (91.9% for men and 90.6% for women).
Almost 80% of multisite MS lasting at least 30 days
involved two or three anatomical regions (77.0% for men
and 77.7% for women).
Discussion
Main results
This study presented analyses of the prevalence of multi-
site MS over a 12-month period in a general population
of workers and described both the type and extent of
other associated MS.
The main results of this study are:
 The frequency and extent of multisite MS were
considerable in this population (2/3 with multisite
MS with more than 90% of these multisite MS
involving more than one anatomical region);
 Although multisite MS were significantly more
frequent in women (68.3%), they were also very
frequent in men (63.2%);
 The prevalence of multisite MS lasting more than
30 days was very high (17.1% men and 22.4% of
women) and these symptoms were widespread (80%
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Figure 1 Distribution of musculoskeletal symptoms lasting at least 30 days according to the number of symptoms. These figures
represent the distribution of musculoskeletal symptoms lasting at least 30 days during the past 12 months according to the number of declared
symptoms among men (figure A) and women (figure B): Neck symptoms (N), Shoulder or upper arm symptoms (S), Elbow or forearm symptoms
(E), Wrist or hand symptoms (W), Upper back symptoms (UB), Low back symptoms (LB), Hip or thigh symptoms (H), Knee or lower leg symptoms
(K), Ankle or foot symptoms (A).
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One of the strong points of this study is the large sample
size (3,710 workers) and the representativity of the study
population. The fact that all workers in France, including
part-time or temporary workers, are submitted to an an-
nual health check-up by an occupational physician in
charge of the medical surveillance of a group of com-
panies confirms that the recruitment of this study, basedTable 4 Prevalence (%) and 95% confidence intervals (CI)
of musculoskeletal symptoms in various anatomical
regions during the past 12 months among men and
women
Symptoms: n (%) CI Men (N= 2,162) Women (N=1,548)
Musculoskeletal symptoms:
Axial 1395 (64.5) 62.5-66.5 996 (64.3) 62.0-66.7
Upper limb (with neck) 1310 (60.6) 58.5-62.7 1067 (68.9) 66.6-71.2
Lower limb 942 (43.6) 41.5-45.7 623 (40.2) 37.8-42.7
Musculoskeletal symptoms lasting at least 30 days:
Axial 383 (17.7) 16.1-19.3 335 (21.6) 19.6-23.7
Upper limb (with neck) 378 (17.5) 15.9-19.1 362 (23.4) 21.3-25.5
Lower limb 322 (14.9) 13.4-16.4 229 (14.8) 13.0-16.6on a network of occupational physicians, is relevant to
study the target population although farmers and self-
employed workers, rarely followed by occupational phy-
sicians, would be underrepresented in this study. The
representativity of the study sample compared to the
population of the region and to the French populationTable 5 Numbers of anatomical regions with
musculoskeletal symptoms during the past 12 months
among men and women
Symptoms: n (%) CI Men (N= 2,162) Women (N=1,548)
No region: 351 (16.2) 14.7-17.8 250 (16.1) 14.3-18.0
One region: 555 (25.7) 23.8-27.5 339 (21.9) 19.8-24.0
Axial 252 (11.7) 10.3-13.0 121 (7.8) 6.5-9.2
Upper limb (with neck) 211 (9.8) 8.5-11.0 184 (11.9) 10.3-13.5
Lower limb 92 (4.3) 3.4-5.1 34 (2.2) 1.5-2.9
Two regions: 676 (31.3) 29.3-33.2 530 (34.2) 31.9-36.6
Axial and upper limb 406 (18.8) 17.1-20.4 370 (23.9) 21.8-26.0
Axial and lower limb 157 (7.3) 6.2-8.4 76 (4.9) 3.8-6.0
Upper and lower limb 113 (5.2) 4.3-6.2 84 (5.4) 4.3-6.6
Three regions: 580 (26.8) 25.0-28.7 429 (27.7) 25.5-29.9
Table 6 Numbers of anatomical regions of
musculoskeletal symptoms lasting at least 30 days
during the past 12 months among men and women
Symptoms: n (%) CI Men (N= 2,162) Women (N=1,548)
No region: 1452 (67.2) 65.2-69.1 971 (62.7) 60.3-65.1
One region: 425 (19.7) 18.0-21.3 308 (19.9) 17.9-21.9
Axial 148 (6.8) 5.8-7.9 101 (6.5) 5.3-7.8
Upper limb (with neck) 149 (6.9) 5.8-8.0 140 (9.0) 7.6-10.5
Lower limb 128 (5.9) 4.9-6.9 67 (4.3) 3.3-5.3
Two regions: 197 (9.1) 7.9-10.3 189 (12.2) 10.6-13.8
Axial and upper limb 91 (4.2) 3.4-5.1 107 (6.9) 5.6-8.2
Axial and lower limb 56 (2.6) 1.9-3.3 47 (3.0) 2.2-3.9
Upper and lower limb 50 (2.3) 1.7-2.9 35 (2.3) 1.5-3.0
Three regions: 88 (4.1) 3.2-4.9 80 (5.2) 4.1-6.3
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parison of their socio-economic status with the last
available French census (1999, http://www.insee.fr), the
distribution of occupations showed no major differences
for either gender with the regional workforce, except for
the few occupations not surveyed by OPs (e.g., shop-
keepers and self-employed workers).
The use of a self-administered questionnaire intro-
duces a reporting bias inherent to this type of data col-
lection leading probably to an over-estimation of recent
and more serious musculoskeletal symptoms [38]. Fur-
thermore, some individuals might have a tendency to re-
port any symptoms, whereas others not report similar
symptoms [39]. However, we have collected no informa-
tion on the personality traits which could influence
reporting patterns of symptoms. The standardized Nordic
questionnaire [38] or derived questionnaires are com-
monly used in epidemiological studies on musculoskeletal
disorders in the workplace or in the general population.
The sensitivity and repeatability of this questionnaire are
good and this questionnaire is likely to have a high utility
in screening and surveillance [40-46]. The French version
of this questionnaire [47] has a good sensitivity (100%)
and moderate specificity (51%) in comparison with the
physical examination of the upper limbs, according to the
study of Descatha and al [48].
Lastly, this cross-sectional study cannot provide any
information about the chronology and course of the
symptoms described.
Prevalence of MS
Estimated prevalences of MS reported in the literature
vary considerably from one study to another, as they are
highly dependent on the definition of musculoskeletal
symptoms (types of symptoms, duration of symptoms
and exposure period considered), the populations inter-
viewed and the context of the study.However, the results of this study are fairly concordant
with those reported in the literature and the general
knowledge on this subject. The prevalence of MS
observed in this study (about 84%) is similar to the
prevalence of 87% reported in several similar studies
[11,13,20].
The results concerning the prevalence of MS by ana-
tomical site over a 12-month period are also globally
consistent with published data.
In a review of the literature [49], the prevalence of low
back symptoms over a 12-month period was between 39
and 67%. The prevalence of 57% observed in the present
study was therefore perfectly consistent with this range,
as well as the estimations published in other studies
[15,21,23,24]. The prevalence of MS of the upper back
(26%) is also concordant with data of the literature (pre-
valences ranging from 6 to 33% [15,22,24]), as are the
prevalences of MS of the elbow (17%, 6 to 21% in the lit-
erature [15,22-24]), hand (25%, 8 to 38% in the literature
[15,18,22-24]) and hip (17%, 6 to 32% in the literature
[15,22,24]).
Published data on the prevalence of MS over a 12-month
period in other sites are more heterogeneous [15,18,
19,22-24]. However, the estimated prevalences reported
in the present study are consistent with published
data, but are situated in the low range for the ankles
or feet (15% in our study and 7 to 27% in the litera-
ture) and in the high range for the neck (40% in our
study and 17 to 48% in the literature), shoulder (36%
in our study and 19 to 39% in the literature) and
knee or lower leg (28% in our study and 11 to 26%
in the literature).
Prevalence of multisite MS
The multisite MS described in this study were slightly
more frequent and more extensive than those reported
in the general population (50% of multisite MS and only
20.6% with MS in 4 or more sites) in the study by
Picavet et al. [15]. When we compare the prevalence of
multisite MS by sex and age group, we observe in our
study in working population that the prevalences were on
average twice as high that those observed in the study of
Picavet in general population. In contrast, Kamaleri [11-14]
reported more frequent and more extensive multisite MS
in a general population cohort (75.4% of multisite MS and
37.5% with MS in 5 or more sites). However, Kamaleri
et al. studied an additional anatomical site, the head, for
which more than 30% of the population reported symp-
toms. This can probably explain the higher prevalence
reported by Kamaleri and al. This anatomical site was not
taken into account in this study, as head symptoms do not
constitute a work-related MS.
High prevalences of multisite musculoskeletal pain are
commonly found in many countries, but the precise
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France and other high income countries is difficult due
to the variability of the methods used. However, the
results of the World Mental Health Surveys (WMHS) of
multiple pains (2 or more sites with pain problems
among the following 4 ones: back/neck pain, headaches,
arthritis, other pain) in the general population are glo-
bally comparable for France and other countries [50].
These results are not comparable because the health
problems taken into account by both studies are not
strictly identical. Despite this limit, this result of the
WMHS illustrate that the problem of the painful symp-
toms is globally comparable in the French population
than in other high income countries.
Our data concerning the number of anatomical sites
of MS differ from those reported by some studies con-
ducted in working populations [18,20,23], as these stud-
ies targeted specific populations and only considered a
limited number of sites (4 to 7 sites).
Yeung [24] reported similar frequencies of multisite
MS in men workers (63.4%) to those reported in this
study (63.9% for men workers), but, as in the study by
Kamaleri, these symptoms were more widespread (22.7%
with MS in 5 or more sites).
Although Haukka [20] only studied pain experienced
during the past three months, he reported similar preva-
lence of MS (73% among female kitchen workers versus
75.6% for female workers in this study) and similar re-
gional distribution of MS to that observed in this study.
Prevalence of MS lasting at least 30 days
The estimated prevalences of MS lasting at least 30 days
presented in this study are concordant with published
data [18,51,52] and clearly confirm the importance of
these subacute or chronic symptoms.
Multisite MS lasting at least 30 days among nurses,
office workers and postal clerks in Crete were more fre-
quent (1/3 versus, in our study, 15.8% for men and
20.9% for women in the service industries), but less
widespread (only 4% with MS lasting at least 30 days in
4 or more sites), in the study by Solidaki [23].
In our study, MS lasting at least 30 days involving
the knee or lower leg and lower back were often iso-
lated. Conversely, MS lasting at least 30 days involving
the upper back, hip and elbow, relatively uncommon
in our study, were usually associated with other MS.
This observation underlines that multisite MS do not
necessarily correspond to the most frequent MS and
suggests the existence of anatomical associations spe-
cific to multisite MS.
Comparison between men and women
In this study, as in several previously published studies
[21,23,33,53], 12-month prevalences were significantlyhigher in women for MS of the neck (+15%) and wrist
(+8%). Twelve-month prevalences were also significantly
higher in women than men for MS of the upper back
(+11%) and shoulder (+5%), but were significantly lower
for the lower back (−5%).
Significant differences, relatively moderate (4 to 6%),
were also observed for MS lasting at least 30 days (with
the exception of the lower back).
These findings are consistent with the observed differ-
ences in the prevalence of multisite MS: multisite MS
were significantly more frequent in women (+5%), in
agreement with the literature. This could reflect not only
a higher tendency in women than men to report pain at
multiple sites [54], but also a higher burden of disease
among women [55]. The sites mostly frequently involved
in women (neck, shoulder, wrist and upper back) also
corresponded to the sites most frequently associated
with others MS (i.e. multisite MS). On the other hand,
MS of the lower back, less frequent in women, often
corresponded to localized MS.
Nevertheless, multisite MS were also reported by a
considerable proportion of men, including widespread
MS (MS involving 5 or more sites).
Recent studies have specifically investigated differences
between men and women [56,57]. Messing et al. demon-
strated that gender was an independent risk factor for
neck and lower limb pain even after adjustment for all
of the identified personal and work-related risk factors.
The proposed explanations for the impact of gender
included different exposures and working conditions
(even within the same type of job), an interaction be-
tween gender and personal factors, as well as biological
and psychological differences. Silverstein et al. also
reported higher prevalence rates of declared MS in
women, but few differences in terms of diagnosed mus-
culoskeletal disorders. Furthermore, in this last study, in-
dependent personal risk factors associated with MS of
the wrist were more advanced age, presence of comor-
bidities and a high body mass index for women, while
only more advanced age was an independent risk factor
for men.
Perspectives
Several studies have demonstrated a poorer state of
health [11,30,58] associated with these multisite MS, es-
pecially in terms of sleep [11,58], comorbidities (other
MS or vascular diseases) [59], functional capacity
[12,15,17,58,60] and quality of life [30,60], and a poorer
occupational prognosis [14,22,61,62]. The risk associated
with these multisite symptoms increases with the num-
ber of sites affected, even after adjustment for the other
identified risk factors [11-14,22].
The presence of regional or widespread MS has also
been reported to be significantly correlated with excess
Parot-Schinkel et al. BMC Musculoskeletal Disorders 2012, 13:122 Page 9 of 11
http://www.biomedcentral.com/1471-2474/13/122mortality compared to subjects not experiencing MS,
with an excess mortality of about 20% for regional pain
(excess cancer mortality) and 30% for WSP (excess can-
cer and cardiovascular mortality), after adjustment for
age, gender and ethnic group [63].
In this study, the presence of multisite MS was asso-
ciated with the female gender and advanced age. How-
ever, the whole working population was concerned since
the prevalence of the multisite MS lasting at least 30 days
for the younger age group was not negligible (9% in men
and 12% in women). The prevalence of multisite symp-
toms was little influenced by occupational categories
and activity sector. So, these results do not allow the
identification of specific risk groups to target future
interventions of prevention.
Conclusions
This study confirms the importance of multisite MS, in-
cluding symptoms lasting at least 30 days. In view of the
poor prognosis associated with these multisite MS, fur-
ther research must be conducted on this subject in order
to more clearly identify the various profiles of multisite
MS and their determinants.
Competing interests
None of the authors has any conflicts of interest to declare.
Authors' contributions
Parot-Schinkel performed the analyses, participated to data interpretation,
wrote the main part of the first version of the manuscript and made
revisions after comments from the other authors. Descatha participated to
data interpretation, to writing the first version of the manuscript and to
comment the different versions of the manuscript. Ha and Leclerc
participated to design the study, to data interpretation, and to comment the
manuscript. Petit participated to data interpretation and to comment the
different versions of the manuscript. Roquelaure designed and conducted
the study, participated to data interpretation, and to comment the
manuscript.
All authors read and approved the final manuscript
Authors’ information
The authors are members of research units in occupational health and A
Descatha, Y Roquelaure and A Leclerc are members of the Musculoskeletal
Committee of the International Commission of Occupational Health (ICOH),
and the French Language Research group on MSD.
Acknowledgements
The authors are grateful to the occupational physicians involved in the
sentinel network: Doctors Abonnat, Banon, Bardet, Becquemie, Bertin,
Bertrand, Bidron, Biton, Bizouarne, Boisse, Bonamy, Bonneau, Bouguer-
Diquelou, Bourrut-Lacouture, Breton, Caillon, Cesbron, Chisacof, Chotard,
Compain, Coquin-Georgeac, Cordes, Couet, Coutand, Danielou, Darcy,
Davenas, De Lansalut, De Lescure, Diquelou, Dopsent, Dufrenne-Benetti,
Dupas, Evano, Fache, Fontaine, Frampas-Chotard, Guillier, Guillimin, Harinte,
Harrigan, Hervio, Hirigoyen, Jahan, Jube, Kalfon, Labraga, Laine-Colin,
Laventure, Le Clerc, Le Dizet, Lechevalier, Ledenvic, Leroux, Leroy-Maguer,
Levrard, Levy, Logeay, Lucas, Mallet, Martin-Laurent, Mazoyer, Meritet, Michel,
Migne-Cousseau, Moisan, Page, Patillot, Pinaud, Pineau, Pizzalla, Plessis,
Plouhinec, Raffray, Robin-Riom, Roussel, Russu, Saboureault, Schlindwein,
Soulard, Thomson, Treillard and Tripodi. The Pays de la Loire study was
supported by The French Institute for Public Health Surveillance. We thank
Anthony Saul who provided traduction services for this article.Author details
1LUNAM Université, Université d’Angers, Laboratoire d’ergonomie et
d’épidémiologie en santé au travail (LEEST), 49045, Angers, France. 2CHU
d’Angers, 49933, Angers, France. 3Université de Versailles St-Quentin, UMRS
1018, Centre for Research in Epidemiology and Population Health,
Population-Based Epidemiological Cohorts Research Platform, 94807, Villejuif,
France. 4Département santé travail, Institut de veille sanitaire, 94415,
Saint-Maurice, France.
Received: 10 August 2011 Accepted: 29 June 2012
Published: 20 July 2012References
1. Woolf AD: The bone and joint decade 2000–2010. Ann Rheum Dis 2000,
59:81–82.
2. European Agency for Safety and Health at Work: Work-related neck and
upperlimb musculoskeletal disorders. Luxembourg: Office for Official
Publications of the European Communities; 1999.
3. European Foundation for the Improvement of Living and Working
Conditions: Third European Survey on Working Conditions 2000. Luxembourg:
Office for Official Publications of the European Communities; 2001.
4. Eurostat: Work and health in the EU: a statistical portrait. Data 1994–2002.
Luxembourg: Office for official publications of the European communities;
2004.
5. Allison TR, Symmons DPM, Brammah T, Haynes P, Rogers A, Roxby M, Urwin
M: Musculoskeletal pain is more generalised among people from ethnic
minorities than among white people in Greater Manchester. Ann Rheum
Dis 2002, 61:151–156.
6. Carnes D, Parsons S, Ashby D, Breen A, Foster NE, Pincus T, Vogel S,
Underwood M: Chronic musculoskeletal pain rarely presents in a single
body site: results from a UK population study. Rheumatology (Oxford)
2007, 46:1168–1170.
7. Davies H, Crombie I, Macrae W: Where does it hurt? Describing the body
locations of chronic pain. Eur J Pain 1998, 2:69–80.
8. Gerdle B, Björk J, Cöster L, Henriksson K, Henriksson C, Bengtsson A:
Prevalence of widespread pain and associations with work status: a
population study. BMC Musculoskelet Disord 2008, 9:102.
9. Harkness EF, Macfarlane GJ, Silman AJ, McBeth J: Is musculoskeletal pain
more common now than 40 years ago?: Two population-based cross-
sectional studies. Rheumatology (Oxford) 2005, 44:890–895.
10. Jordan KP, Kadam UT, Hayward R, Porcheret M, Young C, Croft P: Annual
consultation prevalence of regional musculoskeletal problems in primary
care: an observational study. BMC Musculoskelet Disord 2010, 11:144.
11. Kamaleri Y, Natvig B, Ihlebaek CM, Benth JS, Bruusgaard D: Number of pain
sites is associated with demographic, lifestyle, and health-related factors
in the general population. Eur J Pain 2008, 12:742–748.
12. Kamaleri Y, Natvig B, Ihlebaek CM, Bruusgaard D: Localized or widespread
musculoskeletal pain: does it matter? Pain 2008, 138:41–46.
13. Kamaleri Y, Natvig B, Ihlebaek CM, Benth JS, Bruusgaard D: Change in the
number of musculoskeletal pain sites: A 14-year prospective study. Pain
2009, 141:25–30.
14. Kamaleri Y, Natvig B, Ihlebaek CM, Bruusgaard D: Does the number of
musculoskeletal pain sites predict work disability? A 14-year prospective
study. Eur J Pain 2009, 13:426–430.
15. Picavet HSJ, Schouten JSAG: Musculoskeletal pain in the Netherlands:
prevalences, consequences and risk groups, the DMC(3)-study. Pain 2003,
102:167–178.
16. Schmidt CO, Baumeister SE: Simple patterns behind complex spatial pain
reporting? Assessing a classification of multisite pain reporting in the
general population. Pain 2007, 133:174–182.
17. Urwin M, Symmons D, Allison T, Brammah T, Busby H, Roxby M, Simmons A,
Williams G: Estimating the burden of musculoskeletal disorders in the
community: the comparative prevalence of symptoms at different
anatomical sites, and the relation to social deprivation. Ann Rheum Dis
1998, 57:649–655.
18. Alexopoulos EC, Stathi I-C, Charizani F: Prevalence of musculoskeletal
disorders in dentists. BMC Musculoskelet Disord 2004, 5:16.
19. Alexopoulos EC, Tanagra D, Konstantinou E, Burdorf A: Musculoskeletal
disorders in shipyard industry: prevalence, health care use, and
absenteeism. BMC Musculoskelet Disord 2006, 7:88.
Parot-Schinkel et al. BMC Musculoskeletal Disorders 2012, 13:122 Page 10 of 11
http://www.biomedcentral.com/1471-2474/13/12220. Haukka E, Leino-Arjas P, Solovieva S, Ranta R, Viikari-Juntura E, Riihimäki H:
Co-occurrence of musculoskeletal pain among female kitchen workers.
Int Arch Occup Environ Health 2006, 80:141–148.
21. Kääriä S, Solovieva S, Leino-Arjas P: Associations of low back pain with
neck pain: a study of industrial employees with 5-, 10-, and 28-year
follow-ups. Eur J Pain 2009, 13:406–411.
22. Morken T, Riise T, Moen B, Hauge SHV, Holien S, Langedrag A, Pedersen S,
Saue ILL, Seljebø GM, Thoppil V: Low back pain and widespread pain
predict sickness absence among industrial workers. BMC Musculoskelet
Disord 2003, 4:21.
23. Solidaki E, Chatzi L, Bitsios P, Markatzi I, Plana E, Castro F, Palmer K, Coggon
D, Kogevinas M: Work-related and psychological determinants of
multisite musculoskeletal pain. Scand J Work Environ Health 2010,
36:54–61.
24. Yeung SS, Genaidy A, Deddens J, Alhemood A, Leung PC: Prevalence of
musculoskeletal symptoms in single and multiple body regions and
effects of perceived risk of injury among manual handling workers. Spine
2002, 27:2166–2172.
25. Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrström P: Prevalence of
fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000,
18:149–153.
26. Neumann L, Buskila D: Epidemiology of fibromyalgia. Curr Pain Headache
Rep 2003, 7:362–368.
27. Croft P, Dunn KM, Von Korff M: Chronic pain syndromes: you can’t have
one without another. Pain 2007, 131:237–238.
28. Gummesson C, Atroshi I, Ekdahl C, Johnsson R, Ornstein E: Chronic upper
extremity pain and co-occurring symptoms in a general population.
Arthritis Rheum 2003, 49:697–702.
29. Hagen EM, Svensen E, Eriksen HR, Ihlebaek CM, Ursin H: Comorbid
subjective health complaints in low back pain. Spine 2006, 31:1491–1495.
30. IJzelenberg W, Burdorf A: Impact of musculoskeletal co-morbidity of neck
and upper extremities on healthcare utilisation and sickness absence for
low back pain. Occup Environ Med 2004, 61:806–810.
31. Macfarlane GJ, Hunt IM, Silman AJ: Role of mechanical and psychosocial
factors in the onset of forearm pain: prospective population based
study. BMJ 2000, 321:676–679.
32. Molano SM, Burdorf A, Elders LA: Factors associated with medical
care-seeking due to low-back pain in scaffolders. Am J Ind Med 2001,
40:275–281.
33. Saastamoinen P, Leino-Arjas P, Laaksonen M, Martikainen P, Lahelma E: Pain
and health related functioning among employees. J Epidemiol Community
Health 2006, 60:793–798.
34. Roquelaure Y, Ha C, Leclerc A, Touranchet A, Sauteron M, Melchior M,
Imbernon E, Goldberg M: Epidemiologic surveillance of upper-extremity
musculoskeletal disorders in the working population. Arthritis Rheum
2006, 55:765–778.
35. Ha C, Roquelaure Y, Leclerc A, Touranchet A, Goldberg M, Imbernon E: The
French Musculoskeletal Disorders Surveillance Program: Pays de la Loire
network. Occup Environ Med 2009, 66:471–479.
36. Hagberg M, Silverstein B, Wells R, et al: Work related musculoskeletal disorders
(WMSDs): a reference book for prevention. London: Taylor & Francis; 1995.
37. Descatha A, Roquelaure Y, Chastang J-F, Evanoff B, Cyr D, Leclerc A: Work, a
prognosis factor for upper extremity musculoskeletal disorders? Occup
Environ Med 2009, 66:351–352.
38. Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sørensen F,
Andersson G, Jørgensen K: Standardised Nordic questionnaires for the
analysis of musculoskeletal symptoms. Appl Ergon 1987, 18:233–237.
39. Tschudi-Madsen H, Kjeldsberg M, Natvig B, Ihlebaek C, Dalen I, Kamaleri Y,
Straand J, Bruusgaard D: A strong association between non-
musculoskeletal symptoms and musculoskeletal pain symptoms: results
from a population study. BMC Musculoskelet Disord 2011, 12:285.
40. Dickinson CE, Campion K, Foster AF, Newman SJ, O’Rourke AM, Thomas PG:
Questionnaire development: an examination of the Nordic
Musculoskeletal questionnaire. Appl Ergon 1992, 23:197–201.
41. Ohlsson K, Attewell RG, Johnsson B, Ahlm A, Skerfving S: An assessment of
neck and upper extremity disorders by questionnaire and clinical
examination. Ergonomics 1994, 37:891–897.
42. Baron S, Hales T, Hurrell J: Evaluation of symptom surveys for
occupational musculoskeletal disorders. Am J Ind Med 1996,
29:609–617.43. Silverstein BA, Stetson DS, Keyserling WM, Fine LJ: Work-related
musculoskeletal disorders: comparison of data sources for surveillance.
Am J Ind Med 1997, 31:600–608.
44. Palmer K, Smith G, Kellingray S, Cooper C: Repeatability and validity of
an upper limb and neck discomfort questionnaire: the utility of
the standardized Nordic questionnaire. Occup Med (Lond) 1999,
49:171–175.
45. Nordlund A, Ekberg K: Self reported musculoskeletal symptoms in
the neck/shoulders and/or arms and general health (SF-36): eight
year follow up of a case–control study. Occup Environ Med 2004,
61:e11.
46. Dawson AP, Steele EJ, Hodges PW, Stewart S: Development and test-retest
reliability of an extended version of the Nordic Musculoskeletal
Questionnaire (NMQ-E): a screening instrument for musculoskeletal pain.
J Pain 2009, 10:517–526.
47. Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sorensen F,
Andersson G: Analyse des problèmes de l’appareil locomoteur:
questionnaire scandinave. DMT 1994, 58:167–170.
48. Descatha A, Roquelaure Y, Chastang JF, Evanoff B, Melchior M, Mariot C,
Ha C, Imbernon E, Goldberg M, Leclerc A: Validity of Nordic-style
questionnaires in the surveillance of upper-limb work-related
musculoskeletal disorders. Scand J Work Environ Health 2007,
33:58–65.
49. McBeth J, Jones K: Epidemiology of chronic musculoskeletal pain. Best
Pract Res Clin Rheumatol 2007, 21:403–425.
50. Gureje O, Von Korff M, Kola L, Demyttenaere K, He Y, Posada-Villa J, Lepine
JP, Angermeyer MC, Levinson D, de Girolamo G, Iwata N, Karam A,
Guimaraes Borges GL, de Graaf R, Browne MO, Stein DJ, Haro JM, Bromet EJ,
Kessler RC, Alonso J: The relation between multiple pains and mental
disorders: results from the World Mental Health Surveys. Pain 2008,
135:82–91.
51. Leclerc A, Gourmelen J, Chastang J-F, Plouvier S, Niedhammer I, Lanoë J-L:
Level of education and back pain in France: the role of demographic,
lifestyle and physical work factors. Int Arch Occup Environ Health 2009,
82:643–652.
52. Madan I, Reading I, Palmer KT, Coggon D: Cultural differences in
musculoskeletal symptoms and disability. Int J Epidemiol 2008,
37:1181–1189.
53. Leclerc A, Niedhammer I, Landre MF, Ozguler A, Etore P, Pietri-Taleb F: One-
year predictive factors for various aspects of neck disorders. Spine 1999,
24:1455–1462.
54. Walker-Bone K, Reading I, Coggon D, Cooper C, Palmer KT: The anatomical
pattern and determinants of pain in the neck and upper limbs: an
epidemiologic study. Pain 2004, 109:45–51.
55. Malmusi D, Artazcoz L, Benach J, Borrell C: Perception or real illness?
European Journal of Public Health: How chronic conditions contribute to
gender inequalities in self-rated health; 2011.
56. Messing K, Stock SR, Tissot F: Should studies of risk factors for
musculoskeletal disorders be stratified by gender? Lessons from the
1998 Québec Health and Social Survey. Scand J Work Environ Health 2009,
35:96–112.
57. Silverstein B, Fan ZJ, Smith CK, Bao S, Howard N, Spielholz P, Bonauto D,
Viikari-Juntura E: Gender adjustment or stratification in discerning upper
extremity musculoskeletal disorder risk? Scand J Work Environ Health 2009,
35:113–126.
58. Natvig B, Bruusgaard D, Eriksen W: Localized low back pain and low back
pain as part of widespread musculoskeletal pain: two different
disorders? A cross-sectional population study. J Rehabil Med 2001,
33:21–25.
59. Schneider S, Mohnen SM, Schiltenwolf M, Rau C: Comorbidity of low back
pain: representative outcomes of a national health study in the Federal
Republic of Germany. Eur J Pain 2007, 11:387–397.
60. Salaffi F, De Angelis R, Stancati A, Grassi W: Health-related quality of life in
multiple musculoskeletal conditions: a cross-sectional population based
epidemiological study. II. The MAPPING study. Clin. Exp. Rheumatol 2005,
23:829–839.
61. Miranda H, Kaila-Kangas L, Heliövaara M, Leino-Arjas P, Haukka E, Liira J,
Viikari-Juntura E: Musculoskeletal pain at multiple sites and its effects on
work ability in a general working population. Occup Environ Med 2010,
67:449–455.
Parot-Schinkel et al. BMC Musculoskeletal Disorders 2012, 13:122 Page 11 of 11
http://www.biomedcentral.com/1471-2474/13/12262. Nyman T, Grooten WJA, Wiktorin C, Liwing J, Norrman L: Sickness absence
and concurrent low back and neck-shoulder pain: results from the
MUSIC-Norrtälje study. Eur Spine J 2007, 16:631–638.
63. McBeth J, Symmons DP, Silman AJ, Allison T, Webb R, Brammah T,
Macfarlane GJ: Musculoskeletal pain is associated with a long-term
increased risk of cancer and cardiovascular-related mortality.
Rheumatology (Oxford) 2009, 48:74–77.
doi:10.1186/1471-2474-13-122
Cite this article as: Parot-Schinkel et al.: Prevalence of multisite
musculoskeletal symptoms: a French cross-sectional working
population-based study. BMC Musculoskeletal Disorders 2012 13:122.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
